Carl Icahn Net Worth : $21.3 billion USD
Carl Icahn is a very successful businessman. Carl Icahn Net Worth is $21.3 billion USD.
Quick Points About Carl Icahn :
|Full Name||Carl Celian Icahn|
|Date of Birth||February 16, 1936|
|Place of Birth||Queens, New York City, New York, United States|
|Achievements||Starlight Foundation’s Founders Award|
Born on 16th February, 1936, Carl Celian Icahn is an American business tycoon, a successful investor and a great philanthropist. He is the founder of Icahn Enterprises and is a major stakeholder of the same. Icahn Enterprises is a New York City based powerful conglomerate. Carl is also the Chairman of Federal Mogul- an American development firm and supplier of safety products for vehicles.
Carl was raised in the Queens locality of the city of New York and attended the Far Rockaway High School. Caul was born to a Judaic family and he describes his father as a ‘dogmatic atheist.’ Both his father and mother were teachers. In 1957 Carl received his Bachelor’s degree from Princeton University, where he studied philosophy. Subsequently Carl joined the New York University School of Medicine, only to drop out just after one year to join the army.
Carl’s career began as he started working as a stockbroker on Wall Street in 1961. In 1968 Carl founded the securities firm Icahn & Co. His venture mainly concentrated on options trading and risk arbitrage. In the later 1970s Carl began taking prominent positions in in various individual enterprises. His prominence in various corporations grew as he got controlling status in Kerr-McGee, Netflix, Motorola, American Can, Gulf & Western, Imclone, Phillips Petroleum, RJR Nabisco, Herbalife, Fairmont Hotels, Viacom, Western Union, Marshall Field’s, Uniroyal, E-II (Culligan and Samsonite), USX and TWA.
In the July of 2013 did Carl initiate an attempt to take over Dell Inc. Subsequent to his hostile undertaking of ‘TWA’ in 1985, Carl’s image developed to that of a remorseless “corporate raider”. In 2004, Carl ensured a purchase of heavy stakes in Mylan Laboratories. This was subsequent to Mylan’s announcement of their deal to buy King Pharmaceuticals.
Carl supported Donald Trump for the US presidential elections of 2016.